瑞盧戈利

{{Drugbox
| Verifiedfields =
| Watchedfields =
| verifiedrevid =
| image = Relugolix.svg
| image_class = skin-invert-image
| width = 250
| alt =
| image2 = Relugolix molecule ball.png
| image_class2 = bg-transparent
| width2 = 250
| alt2 =

| pronounce =

| tradename = Orgovyx, Relumina
| Drugs.com =
| MedlinePlus = a621006
| DailyMedID = Relugolix
| pregnancy_AU =
| pregnancy_AU_comment =
| pregnancy_category=
| routes_of_administration = 口服
| legal_BR =
| legal_BR_comment =
| legal_CA = Rx-only
| legal_CA_comment =
| legal_DE =
| legal_DE_comment =
| legal_NZ =
| legal_NZ_comment =
| legal_UK =
| legal_UK_comment =
| legal_US = Rx-only
| legal_US_comment =
| legal_EU = Rx-only
| legal_EU_comment =
| legal_UN =
| legal_UN_comment =
| legal_status =

| bioavailability =
| protein_bound = 68–71%。 以口服方式使用。 它可將男女體內的性激素濃度抑制至更年期後或閹割水準。

延伸閱讀
*
*
*

參考文獻
外部連結
*